Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis (2022) Marino S, Hannemann N, Bishop RT, Zeng F, Carrasco G, Meurisse S, Li B, et al. Journal article The indirubin derivative 6-bromoindirubin-3′-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference (2020) Czapka A, König S, Pergola C, Grune C, Vougogiannopoulou K, Skaltsounis AL, Fischer D, Werz O Journal article Therapeutic opportunities for targeting cold pain pathways (2015) Yin K, Zimmermann K, Vetter I, Lewis RJ Journal article Akt and p53 are potential mediators of reduced mammary tumor growth by Chloroquine and the mTOR inhibitor RAD001 (2012) Löhberg C, Strissel P, Dittrich R, Strick R, Dittmer J, Dittmer A, Fabry B, et al. Journal article Akt and p53 are potential mediators of reduced mammary tumor growth by Chloroquine and the mTOR inhibitor RAD001 (2012) Löhberg C, Strissel P, Dittrich R, Strick R, Dittmer J, Dittmer A, Fabry B, et al. Journal article Inhibition of Rho kinases increases directional motility of microvascular endothelial cells (2012) Breyer J, Samarin J, Rehm M, Lautscham L, Fabry B, Goppelt-Strübe M Journal article Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice (2003) Gmeiner P Journal article